Skip to main content

Table 3 Prevalence of high-risk human papillomavirus genotypes according to the vaccine-targeted high-risk human papillomavirus genotypes

From: Prevalence of high-risk HPV genotypes, categorised by their quadrivalent and nine-valent HPV vaccination coverage, and the genotype association with high-grade lesions

   Total    
   n = 595 % 95%CI  
Regarding HPV genotype
 No high-riska   160 26.89 23.24 30.54
 At least 1 high-risk   435 73.11 69.46 76.76
According to the vaccine-targeted high-risk HPV genotypes
 No high-riska   160 26.89 23.24 30.54
 Quadrivalent HPV non-vaccine-targeted high-risk HPV genotypesb   229 38.49 34.49 42.48
  Quadrivalent HPV and nine-valent HPV non-vaccine-targeted high-risk HPV genotypesc 107 17.98 14.81 21.15
  Additional five high-risk HPV genotypes present in the nine-valent HPV vaccined 122 20.50 17.18 23.83
 Vaccine-targeted high-risk HPV genotypes (16 or 18)   201 33.78 29.90 37.67
 Vaccine-targeted high-risk HPV genotypes (16 and 18)   5 0.84 0.27 1.95
  1. aNo high-risk. Classification human papillomavirus (HPV) types according to the World Health Organization International Agency for Research on Cancer (IARC) Monographs Working Group assessment of the carcinogenicity of different HPV types [25,26,27]
  2. bAt least 1 of the quadrivalent HPV non-vaccine-targeted high-risk HPV genotypes (31 or 33 or 35 or 39 or 45 or 51 or 52 or 56 or 58 or 59 or 68)
  3. cAt least 1 of the quadrivalent HPV and nine-valent HPV non-vaccine-targeted high-risk HPV genotypes (35 or 39 or 51 or 56 or 59 or 68)
  4. dAt least 1 of the additional five high-risk HPV genotypes present in the nine-valent HPV vaccine (31 or 33 or 45 or 52 or 58)